Review




Structured Review

BioResource International Inc human synovial sarcoma cell line sw982
Cytotoxicity of epinecidin-1 (epi-1) on human synovial sarcoma cells. <t>SW982</t> cells were treated with indicated doses of epi-1 for 5 h. Cytotoxicity was analyzed by the trypan blue exclusion assay ( A ) and MTS/PMS assay ( B ). Cells were treated with epi-1 (6.125 μM) at different time points (0.5, 1, 3, 5 h). Cytotoxicity was analyzed by the trypan blue exclusion assay ( C ) and MTS/PMS assay ( D ). Cells were treated with epi-1 (6.125 μM) or scrambled epi-1 (scr-epi-1) (6.125 μM) for 5 h, and cytotoxicity was determined by the trypan blue exclusion assay ( E ) and MTS/PMS assay ( F ). * p < 0.05 was considered significant.
Human Synovial Sarcoma Cell Line Sw982, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human synovial sarcoma cell line sw982/product/BioResource International Inc
Average 90 stars, based on 1 article reviews
human synovial sarcoma cell line sw982 - by Bioz Stars, 2026-04
90/100 stars

Images

1) Product Images from "Calcium-Dependent Calpain Activation-Mediated Mitochondrial Dysfunction and Oxidative Stress Are Required for Cytotoxicity of Epinecidin-1 in Human Synovial Sarcoma SW982 Cells"

Article Title: Calcium-Dependent Calpain Activation-Mediated Mitochondrial Dysfunction and Oxidative Stress Are Required for Cytotoxicity of Epinecidin-1 in Human Synovial Sarcoma SW982 Cells

Journal: International Journal of Molecular Sciences

doi: 10.3390/ijms21062109

Cytotoxicity of epinecidin-1 (epi-1) on human synovial sarcoma cells. SW982 cells were treated with indicated doses of epi-1 for 5 h. Cytotoxicity was analyzed by the trypan blue exclusion assay ( A ) and MTS/PMS assay ( B ). Cells were treated with epi-1 (6.125 μM) at different time points (0.5, 1, 3, 5 h). Cytotoxicity was analyzed by the trypan blue exclusion assay ( C ) and MTS/PMS assay ( D ). Cells were treated with epi-1 (6.125 μM) or scrambled epi-1 (scr-epi-1) (6.125 μM) for 5 h, and cytotoxicity was determined by the trypan blue exclusion assay ( E ) and MTS/PMS assay ( F ). * p < 0.05 was considered significant.
Figure Legend Snippet: Cytotoxicity of epinecidin-1 (epi-1) on human synovial sarcoma cells. SW982 cells were treated with indicated doses of epi-1 for 5 h. Cytotoxicity was analyzed by the trypan blue exclusion assay ( A ) and MTS/PMS assay ( B ). Cells were treated with epi-1 (6.125 μM) at different time points (0.5, 1, 3, 5 h). Cytotoxicity was analyzed by the trypan blue exclusion assay ( C ) and MTS/PMS assay ( D ). Cells were treated with epi-1 (6.125 μM) or scrambled epi-1 (scr-epi-1) (6.125 μM) for 5 h, and cytotoxicity was determined by the trypan blue exclusion assay ( E ) and MTS/PMS assay ( F ). * p < 0.05 was considered significant.

Techniques Used: Trypan Blue Exclusion Assay



Similar Products

96
ATCC human synovial sarcoma cell line sw982
( A , B ) Tcr-T1 cells were generated as mentioned in the methods. Schematic for TCR-T cell generation, purification, and in vitro expansion. ( A ) Representative flow cytometric images indicated the electroporation efficiency and purification of Tcr-T1 cells ( B ). ( C ) HLA-A*2402-positive MKN45-Luci cells were treated with Tcr-T1 cells, with or without Pep-4 pulsing. 24 h later, cell viability was tested via CCK-8 assay. ( D ) Human synovial sarcoma cell line <t>SW982</t> was modified with stable expression of the HLA-A*2402 molecule to generate target cells (SW982/2402). Then these target cells, SW982 and SW982/2402, were transfected with vectors expressing SYT-SSX fusion mutated peptide containing/deleting Pep-4 sequence (SYT-SSX ΔPep4, SYT-SSX, SYT-SSX ΔPep4/2402, and SYT-SSX/2402). Target cells were incubated with Tcr-T1 cells at ratio 0:1, 0.2:1, 1:1, and 5:1 (T-cell/SW982). Cell viability was determined by using CCK-8. ( E ) SW982 cells overexpressing HLA-A*2402 and SYT-SSX fusion mutated peptide containing Pep-4 sequence (SYT-SSX/2402) were incubated with Tcr-T1 cells ( E : T = 1:1). Cell viability was determined by CCK-8. IFN-γ secretion was examined using a CBA assay ( n = 3 independent replication). ( F ) Cytotoxicity of Tcr-T1 against HLA-A*2402-positive MKN45 was determined as indicated ( n = 3 independent replication). ( G – I ) Treatment scheme ( G , up). SYT-SSX/2402 and SYT-SSX ΔPep4/2402 cells (1 × 10 7 cells/mouse) were injected subcutaneously in nude mice ( n = 6). When tumor volume reached to ~100 mm 3 , Tcr-T1 cells, and UTD T cells (5 × 10 6 cells/mouse) were intravenously injected. Mice were sacrificed at the endpoint. Representative photographs of tumor tissues isolated from each group of mice ( G , bottom). Tumor volumes of each group were recorded ( H ). The overall survival of each group was recorded. ( I ) Data are presented as mean ± SEM. Statistical significance was calculated using the Student’s t test ( C , E ), one-way ANOVA ( C ), two-way ANOVA ( D – F , H ), and Kaplan–Meier survival analysis ( I ). ns not significant, * P < 0.05; ** P < 0.01; *** P < 0.001. .
Human Synovial Sarcoma Cell Line Sw982, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human synovial sarcoma cell line sw982/product/ATCC
Average 96 stars, based on 1 article reviews
human synovial sarcoma cell line sw982 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

90
China Center for Type Culture Collection human synovial sarcoma cell line sw982
( A , B ) Tcr-T1 cells were generated as mentioned in the methods. Schematic for TCR-T cell generation, purification, and in vitro expansion. ( A ) Representative flow cytometric images indicated the electroporation efficiency and purification of Tcr-T1 cells ( B ). ( C ) HLA-A*2402-positive MKN45-Luci cells were treated with Tcr-T1 cells, with or without Pep-4 pulsing. 24 h later, cell viability was tested via CCK-8 assay. ( D ) Human synovial sarcoma cell line <t>SW982</t> was modified with stable expression of the HLA-A*2402 molecule to generate target cells (SW982/2402). Then these target cells, SW982 and SW982/2402, were transfected with vectors expressing SYT-SSX fusion mutated peptide containing/deleting Pep-4 sequence (SYT-SSX ΔPep4, SYT-SSX, SYT-SSX ΔPep4/2402, and SYT-SSX/2402). Target cells were incubated with Tcr-T1 cells at ratio 0:1, 0.2:1, 1:1, and 5:1 (T-cell/SW982). Cell viability was determined by using CCK-8. ( E ) SW982 cells overexpressing HLA-A*2402 and SYT-SSX fusion mutated peptide containing Pep-4 sequence (SYT-SSX/2402) were incubated with Tcr-T1 cells ( E : T = 1:1). Cell viability was determined by CCK-8. IFN-γ secretion was examined using a CBA assay ( n = 3 independent replication). ( F ) Cytotoxicity of Tcr-T1 against HLA-A*2402-positive MKN45 was determined as indicated ( n = 3 independent replication). ( G – I ) Treatment scheme ( G , up). SYT-SSX/2402 and SYT-SSX ΔPep4/2402 cells (1 × 10 7 cells/mouse) were injected subcutaneously in nude mice ( n = 6). When tumor volume reached to ~100 mm 3 , Tcr-T1 cells, and UTD T cells (5 × 10 6 cells/mouse) were intravenously injected. Mice were sacrificed at the endpoint. Representative photographs of tumor tissues isolated from each group of mice ( G , bottom). Tumor volumes of each group were recorded ( H ). The overall survival of each group was recorded. ( I ) Data are presented as mean ± SEM. Statistical significance was calculated using the Student’s t test ( C , E ), one-way ANOVA ( C ), two-way ANOVA ( D – F , H ), and Kaplan–Meier survival analysis ( I ). ns not significant, * P < 0.05; ** P < 0.01; *** P < 0.001. .
Human Synovial Sarcoma Cell Line Sw982, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human synovial sarcoma cell line sw982/product/China Center for Type Culture Collection
Average 90 stars, based on 1 article reviews
human synovial sarcoma cell line sw982 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

96
ATCC human synovial sarcoma sw982 cell lines
( A , B ) Tcr-T1 cells were generated as mentioned in the methods. Schematic for TCR-T cell generation, purification, and in vitro expansion. ( A ) Representative flow cytometric images indicated the electroporation efficiency and purification of Tcr-T1 cells ( B ). ( C ) HLA-A*2402-positive MKN45-Luci cells were treated with Tcr-T1 cells, with or without Pep-4 pulsing. 24 h later, cell viability was tested via CCK-8 assay. ( D ) Human synovial sarcoma cell line <t>SW982</t> was modified with stable expression of the HLA-A*2402 molecule to generate target cells (SW982/2402). Then these target cells, SW982 and SW982/2402, were transfected with vectors expressing SYT-SSX fusion mutated peptide containing/deleting Pep-4 sequence (SYT-SSX ΔPep4, SYT-SSX, SYT-SSX ΔPep4/2402, and SYT-SSX/2402). Target cells were incubated with Tcr-T1 cells at ratio 0:1, 0.2:1, 1:1, and 5:1 (T-cell/SW982). Cell viability was determined by using CCK-8. ( E ) SW982 cells overexpressing HLA-A*2402 and SYT-SSX fusion mutated peptide containing Pep-4 sequence (SYT-SSX/2402) were incubated with Tcr-T1 cells ( E : T = 1:1). Cell viability was determined by CCK-8. IFN-γ secretion was examined using a CBA assay ( n = 3 independent replication). ( F ) Cytotoxicity of Tcr-T1 against HLA-A*2402-positive MKN45 was determined as indicated ( n = 3 independent replication). ( G – I ) Treatment scheme ( G , up). SYT-SSX/2402 and SYT-SSX ΔPep4/2402 cells (1 × 10 7 cells/mouse) were injected subcutaneously in nude mice ( n = 6). When tumor volume reached to ~100 mm 3 , Tcr-T1 cells, and UTD T cells (5 × 10 6 cells/mouse) were intravenously injected. Mice were sacrificed at the endpoint. Representative photographs of tumor tissues isolated from each group of mice ( G , bottom). Tumor volumes of each group were recorded ( H ). The overall survival of each group was recorded. ( I ) Data are presented as mean ± SEM. Statistical significance was calculated using the Student’s t test ( C , E ), one-way ANOVA ( C ), two-way ANOVA ( D – F , H ), and Kaplan–Meier survival analysis ( I ). ns not significant, * P < 0.05; ** P < 0.01; *** P < 0.001. .
Human Synovial Sarcoma Sw982 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human synovial sarcoma sw982 cell lines/product/ATCC
Average 96 stars, based on 1 article reviews
human synovial sarcoma sw982 cell lines - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

90
Procell Inc sw982 human synovial sarcoma cell line
( A , B ) Tcr-T1 cells were generated as mentioned in the methods. Schematic for TCR-T cell generation, purification, and in vitro expansion. ( A ) Representative flow cytometric images indicated the electroporation efficiency and purification of Tcr-T1 cells ( B ). ( C ) HLA-A*2402-positive MKN45-Luci cells were treated with Tcr-T1 cells, with or without Pep-4 pulsing. 24 h later, cell viability was tested via CCK-8 assay. ( D ) Human synovial sarcoma cell line <t>SW982</t> was modified with stable expression of the HLA-A*2402 molecule to generate target cells (SW982/2402). Then these target cells, SW982 and SW982/2402, were transfected with vectors expressing SYT-SSX fusion mutated peptide containing/deleting Pep-4 sequence (SYT-SSX ΔPep4, SYT-SSX, SYT-SSX ΔPep4/2402, and SYT-SSX/2402). Target cells were incubated with Tcr-T1 cells at ratio 0:1, 0.2:1, 1:1, and 5:1 (T-cell/SW982). Cell viability was determined by using CCK-8. ( E ) SW982 cells overexpressing HLA-A*2402 and SYT-SSX fusion mutated peptide containing Pep-4 sequence (SYT-SSX/2402) were incubated with Tcr-T1 cells ( E : T = 1:1). Cell viability was determined by CCK-8. IFN-γ secretion was examined using a CBA assay ( n = 3 independent replication). ( F ) Cytotoxicity of Tcr-T1 against HLA-A*2402-positive MKN45 was determined as indicated ( n = 3 independent replication). ( G – I ) Treatment scheme ( G , up). SYT-SSX/2402 and SYT-SSX ΔPep4/2402 cells (1 × 10 7 cells/mouse) were injected subcutaneously in nude mice ( n = 6). When tumor volume reached to ~100 mm 3 , Tcr-T1 cells, and UTD T cells (5 × 10 6 cells/mouse) were intravenously injected. Mice were sacrificed at the endpoint. Representative photographs of tumor tissues isolated from each group of mice ( G , bottom). Tumor volumes of each group were recorded ( H ). The overall survival of each group was recorded. ( I ) Data are presented as mean ± SEM. Statistical significance was calculated using the Student’s t test ( C , E ), one-way ANOVA ( C ), two-way ANOVA ( D – F , H ), and Kaplan–Meier survival analysis ( I ). ns not significant, * P < 0.05; ** P < 0.01; *** P < 0.001. .
Sw982 Human Synovial Sarcoma Cell Line, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sw982 human synovial sarcoma cell line/product/Procell Inc
Average 90 stars, based on 1 article reviews
sw982 human synovial sarcoma cell line - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

96
ATCC sw982 human synovial sarcoma cell line
TP4 triggers cell death in synovial sarcoma cells. Dose-dependent cytotoxicity of TP4 in <t>SW982</t> cells ( A , B ) and Aska-SS cells ( C ). Cells were incubated with various concentrations of TP4 for 5 h. Time-dependent cytotoxicity of TP4 in SW982 cells ( D , E ) and Aska-SS cells ( F ). Cells were treated with TP4 (20 μg/mL) for the indicated times. Cytotoxicity was determined by the MTS/PMS assay ( A , C , D , F ) and trypan blue exclusion assay ( B , E ). *: p < 0.05 (Compared to 0 min or 0 μg/mL). IC50 values were calculated with GraphPad Prism 8 using a non-linear regression fit (log(inhibitor) vs. normalized response—variable slope).
Sw982 Human Synovial Sarcoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sw982 human synovial sarcoma cell line/product/ATCC
Average 96 stars, based on 1 article reviews
sw982 human synovial sarcoma cell line - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier

90
BioResource International Inc human synovial sarcoma cell line sw982
Cytotoxicity of epinecidin-1 (epi-1) on human synovial sarcoma cells. <t>SW982</t> cells were treated with indicated doses of epi-1 for 5 h. Cytotoxicity was analyzed by the trypan blue exclusion assay ( A ) and MTS/PMS assay ( B ). Cells were treated with epi-1 (6.125 μM) at different time points (0.5, 1, 3, 5 h). Cytotoxicity was analyzed by the trypan blue exclusion assay ( C ) and MTS/PMS assay ( D ). Cells were treated with epi-1 (6.125 μM) or scrambled epi-1 (scr-epi-1) (6.125 μM) for 5 h, and cytotoxicity was determined by the trypan blue exclusion assay ( E ) and MTS/PMS assay ( F ). * p < 0.05 was considered significant.
Human Synovial Sarcoma Cell Line Sw982, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human synovial sarcoma cell line sw982/product/BioResource International Inc
Average 90 stars, based on 1 article reviews
human synovial sarcoma cell line sw982 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


( A , B ) Tcr-T1 cells were generated as mentioned in the methods. Schematic for TCR-T cell generation, purification, and in vitro expansion. ( A ) Representative flow cytometric images indicated the electroporation efficiency and purification of Tcr-T1 cells ( B ). ( C ) HLA-A*2402-positive MKN45-Luci cells were treated with Tcr-T1 cells, with or without Pep-4 pulsing. 24 h later, cell viability was tested via CCK-8 assay. ( D ) Human synovial sarcoma cell line SW982 was modified with stable expression of the HLA-A*2402 molecule to generate target cells (SW982/2402). Then these target cells, SW982 and SW982/2402, were transfected with vectors expressing SYT-SSX fusion mutated peptide containing/deleting Pep-4 sequence (SYT-SSX ΔPep4, SYT-SSX, SYT-SSX ΔPep4/2402, and SYT-SSX/2402). Target cells were incubated with Tcr-T1 cells at ratio 0:1, 0.2:1, 1:1, and 5:1 (T-cell/SW982). Cell viability was determined by using CCK-8. ( E ) SW982 cells overexpressing HLA-A*2402 and SYT-SSX fusion mutated peptide containing Pep-4 sequence (SYT-SSX/2402) were incubated with Tcr-T1 cells ( E : T = 1:1). Cell viability was determined by CCK-8. IFN-γ secretion was examined using a CBA assay ( n = 3 independent replication). ( F ) Cytotoxicity of Tcr-T1 against HLA-A*2402-positive MKN45 was determined as indicated ( n = 3 independent replication). ( G – I ) Treatment scheme ( G , up). SYT-SSX/2402 and SYT-SSX ΔPep4/2402 cells (1 × 10 7 cells/mouse) were injected subcutaneously in nude mice ( n = 6). When tumor volume reached to ~100 mm 3 , Tcr-T1 cells, and UTD T cells (5 × 10 6 cells/mouse) were intravenously injected. Mice were sacrificed at the endpoint. Representative photographs of tumor tissues isolated from each group of mice ( G , bottom). Tumor volumes of each group were recorded ( H ). The overall survival of each group was recorded. ( I ) Data are presented as mean ± SEM. Statistical significance was calculated using the Student’s t test ( C , E ), one-way ANOVA ( C ), two-way ANOVA ( D – F , H ), and Kaplan–Meier survival analysis ( I ). ns not significant, * P < 0.05; ** P < 0.01; *** P < 0.001. .

Journal: EMBO Molecular Medicine

Article Title: A therapeutic regimen using neoantigen-specific TCR-T cells for HLA-A*2402-positive solid tumors

doi: 10.1038/s44321-024-00184-1

Figure Lengend Snippet: ( A , B ) Tcr-T1 cells were generated as mentioned in the methods. Schematic for TCR-T cell generation, purification, and in vitro expansion. ( A ) Representative flow cytometric images indicated the electroporation efficiency and purification of Tcr-T1 cells ( B ). ( C ) HLA-A*2402-positive MKN45-Luci cells were treated with Tcr-T1 cells, with or without Pep-4 pulsing. 24 h later, cell viability was tested via CCK-8 assay. ( D ) Human synovial sarcoma cell line SW982 was modified with stable expression of the HLA-A*2402 molecule to generate target cells (SW982/2402). Then these target cells, SW982 and SW982/2402, were transfected with vectors expressing SYT-SSX fusion mutated peptide containing/deleting Pep-4 sequence (SYT-SSX ΔPep4, SYT-SSX, SYT-SSX ΔPep4/2402, and SYT-SSX/2402). Target cells were incubated with Tcr-T1 cells at ratio 0:1, 0.2:1, 1:1, and 5:1 (T-cell/SW982). Cell viability was determined by using CCK-8. ( E ) SW982 cells overexpressing HLA-A*2402 and SYT-SSX fusion mutated peptide containing Pep-4 sequence (SYT-SSX/2402) were incubated with Tcr-T1 cells ( E : T = 1:1). Cell viability was determined by CCK-8. IFN-γ secretion was examined using a CBA assay ( n = 3 independent replication). ( F ) Cytotoxicity of Tcr-T1 against HLA-A*2402-positive MKN45 was determined as indicated ( n = 3 independent replication). ( G – I ) Treatment scheme ( G , up). SYT-SSX/2402 and SYT-SSX ΔPep4/2402 cells (1 × 10 7 cells/mouse) were injected subcutaneously in nude mice ( n = 6). When tumor volume reached to ~100 mm 3 , Tcr-T1 cells, and UTD T cells (5 × 10 6 cells/mouse) were intravenously injected. Mice were sacrificed at the endpoint. Representative photographs of tumor tissues isolated from each group of mice ( G , bottom). Tumor volumes of each group were recorded ( H ). The overall survival of each group was recorded. ( I ) Data are presented as mean ± SEM. Statistical significance was calculated using the Student’s t test ( C , E ), one-way ANOVA ( C ), two-way ANOVA ( D – F , H ), and Kaplan–Meier survival analysis ( I ). ns not significant, * P < 0.05; ** P < 0.01; *** P < 0.001. .

Article Snippet: Human synovial sarcoma cell line SW982 (HLA-A24-, SYT/SSX fusion-negative), human gastric adenocarcinoma cell line MKN45 (HLA-A24 + , SYT/SSX fusion-negative), human breast cancer cell line MDA-MB-231 (HLA-A02 + , SYT/SSX fusion-negative) and human transporter-associated protein (TAP)-deficient cell line T2 was originally purchased from ATCC, China Center for Type Culture Collection (CCTCC) and the typical cell culture collection of the Committee of the Chinese Academy of Sciences Library.

Techniques: Generated, Purification, In Vitro, Electroporation, CCK-8 Assay, Modification, Expressing, Transfection, Sequencing, Incubation, Injection, Isolation

Reagents and tools table

Journal: EMBO Molecular Medicine

Article Title: A therapeutic regimen using neoantigen-specific TCR-T cells for HLA-A*2402-positive solid tumors

doi: 10.1038/s44321-024-00184-1

Figure Lengend Snippet: Reagents and tools table

Article Snippet: Human synovial sarcoma cell line SW982 (HLA-A24-, SYT/SSX fusion-negative), human gastric adenocarcinoma cell line MKN45 (HLA-A24 + , SYT/SSX fusion-negative), human breast cancer cell line MDA-MB-231 (HLA-A02 + , SYT/SSX fusion-negative) and human transporter-associated protein (TAP)-deficient cell line T2 was originally purchased from ATCC, China Center for Type Culture Collection (CCTCC) and the typical cell culture collection of the Committee of the Chinese Academy of Sciences Library.

Techniques: Cell Culture, Recombinant, Bicinchoninic Acid Protein Assay, Software

TP4 triggers cell death in synovial sarcoma cells. Dose-dependent cytotoxicity of TP4 in SW982 cells ( A , B ) and Aska-SS cells ( C ). Cells were incubated with various concentrations of TP4 for 5 h. Time-dependent cytotoxicity of TP4 in SW982 cells ( D , E ) and Aska-SS cells ( F ). Cells were treated with TP4 (20 μg/mL) for the indicated times. Cytotoxicity was determined by the MTS/PMS assay ( A , C , D , F ) and trypan blue exclusion assay ( B , E ). *: p < 0.05 (Compared to 0 min or 0 μg/mL). IC50 values were calculated with GraphPad Prism 8 using a non-linear regression fit (log(inhibitor) vs. normalized response—variable slope).

Journal: Marine Drugs

Article Title: Marine Antimicrobial Peptide TP4 Exerts Anticancer Effects on Human Synovial Sarcoma Cells via Calcium Overload, Reactive Oxygen Species Production and Mitochondrial Hyperpolarization

doi: 10.3390/md19020093

Figure Lengend Snippet: TP4 triggers cell death in synovial sarcoma cells. Dose-dependent cytotoxicity of TP4 in SW982 cells ( A , B ) and Aska-SS cells ( C ). Cells were incubated with various concentrations of TP4 for 5 h. Time-dependent cytotoxicity of TP4 in SW982 cells ( D , E ) and Aska-SS cells ( F ). Cells were treated with TP4 (20 μg/mL) for the indicated times. Cytotoxicity was determined by the MTS/PMS assay ( A , C , D , F ) and trypan blue exclusion assay ( B , E ). *: p < 0.05 (Compared to 0 min or 0 μg/mL). IC50 values were calculated with GraphPad Prism 8 using a non-linear regression fit (log(inhibitor) vs. normalized response—variable slope).

Article Snippet: The SW982 human synovial sarcoma cell line was purchased from ATCC (The Global Bioresource Center; Manassas, VA, USA).

Techniques: Incubation, Trypan Blue Exclusion Assay

Necrotic cell death is induced by TP4 in synovial sarcoma cells. Cells were treated with TP4 (20 μg/mL) or staurosporine (1 μM) for 5 h and 24 h, respectively. Vehicle control was 0.5% DMSO. Necrotic cell death was determined by the propidium iodide incorporation assay ( A ). ( B ) Cells (SW982 and Aska-SS) were treated as described above. Cell lysates and culture supernatants were collected and immunoblotted with indicated antibodies. Band intensities were analyzed with ImageJ software. *: p < 0.05 (Compared to vehicle). Cells (SW982 and Aska-SS) were preincubated with GSK’872 (5 μM) ( C , E ), Necrostatin-1 (10 μM) ( D , F ), or Z-VAD-FMK (100 μM) ( G , H ) for 1 h, followed by TP4 (20 μg/mL) for additional 5 h. Cell viability was analyzed using the trypan blue exclusion assay. *: p < 0.05 (Vehicle vs. TP4; TP4 vs. TP4 + inhibitor). Vehicle control: appropriate amount of DMSO.

Journal: Marine Drugs

Article Title: Marine Antimicrobial Peptide TP4 Exerts Anticancer Effects on Human Synovial Sarcoma Cells via Calcium Overload, Reactive Oxygen Species Production and Mitochondrial Hyperpolarization

doi: 10.3390/md19020093

Figure Lengend Snippet: Necrotic cell death is induced by TP4 in synovial sarcoma cells. Cells were treated with TP4 (20 μg/mL) or staurosporine (1 μM) for 5 h and 24 h, respectively. Vehicle control was 0.5% DMSO. Necrotic cell death was determined by the propidium iodide incorporation assay ( A ). ( B ) Cells (SW982 and Aska-SS) were treated as described above. Cell lysates and culture supernatants were collected and immunoblotted with indicated antibodies. Band intensities were analyzed with ImageJ software. *: p < 0.05 (Compared to vehicle). Cells (SW982 and Aska-SS) were preincubated with GSK’872 (5 μM) ( C , E ), Necrostatin-1 (10 μM) ( D , F ), or Z-VAD-FMK (100 μM) ( G , H ) for 1 h, followed by TP4 (20 μg/mL) for additional 5 h. Cell viability was analyzed using the trypan blue exclusion assay. *: p < 0.05 (Vehicle vs. TP4; TP4 vs. TP4 + inhibitor). Vehicle control: appropriate amount of DMSO.

Article Snippet: The SW982 human synovial sarcoma cell line was purchased from ATCC (The Global Bioresource Center; Manassas, VA, USA).

Techniques: Control, Software, Trypan Blue Exclusion Assay

TP4 triggers oxidative stress. Synovial sarcoma cells were treated with TP4 (20 μg/mL) for the indicated times, and intracellular ROS was evaluated by DCF-DA ( A , B , E , F ) and DHE ( C , D ) fluorescence using flow cytometry. *: p < 0.05 (compared to 0 min). SW982 ( G ) and AsKa-SS ( H ) cells were preincubated with TEMPO (150 μM) for 1 h, followed by TP4 (20 μg/mL) for additional 5 h. Cell viability was determined using the trypan exclusion assay. *: p < 0.05 (Vehicle vs. TP4; TP4 vs. TP4 + TEMPO). ( I ) SW982 cells were treated with TP4 (20 μg/mL) for the indicated times, and cell lysates were collected and immunoblotted with the indicated antibodies. UCP-2: uncoupling protein-2; GPx: glutathione peroxidase; SOD-1: superoxide dismutase-1; SOD-2: superoxide dismutase-2. ( J – N ) Band intensities were analyzed with ImageJ. *: p < 0.05 (Compared to 0 min).

Journal: Marine Drugs

Article Title: Marine Antimicrobial Peptide TP4 Exerts Anticancer Effects on Human Synovial Sarcoma Cells via Calcium Overload, Reactive Oxygen Species Production and Mitochondrial Hyperpolarization

doi: 10.3390/md19020093

Figure Lengend Snippet: TP4 triggers oxidative stress. Synovial sarcoma cells were treated with TP4 (20 μg/mL) for the indicated times, and intracellular ROS was evaluated by DCF-DA ( A , B , E , F ) and DHE ( C , D ) fluorescence using flow cytometry. *: p < 0.05 (compared to 0 min). SW982 ( G ) and AsKa-SS ( H ) cells were preincubated with TEMPO (150 μM) for 1 h, followed by TP4 (20 μg/mL) for additional 5 h. Cell viability was determined using the trypan exclusion assay. *: p < 0.05 (Vehicle vs. TP4; TP4 vs. TP4 + TEMPO). ( I ) SW982 cells were treated with TP4 (20 μg/mL) for the indicated times, and cell lysates were collected and immunoblotted with the indicated antibodies. UCP-2: uncoupling protein-2; GPx: glutathione peroxidase; SOD-1: superoxide dismutase-1; SOD-2: superoxide dismutase-2. ( J – N ) Band intensities were analyzed with ImageJ. *: p < 0.05 (Compared to 0 min).

Article Snippet: The SW982 human synovial sarcoma cell line was purchased from ATCC (The Global Bioresource Center; Manassas, VA, USA).

Techniques: Fluorescence, Flow Cytometry, Exclusion Assay

TP4 induces mitochondrial hyperpolarization and mitochondrial ROS generation. SW982 ( A , B ) and AsKa-SS ( C , D ) cells were treated with TP4 (20 μg/mL) for 0, 15, 30, 60, 180 and 300 min. TMRE intensity was analyzed by flow cytometry. SW982 ( E , F ) and AsKa-SS ( G , H ) cells were treated with TP4 (20 μg/mL), as described in ( A – D ), followed by MitoSOX Red (5 μM) for an additional 15 min. MitoSOX Red fluorescence intensity was determined by flow cytometry. *: p < 0.05 (Compared to 0 min).

Journal: Marine Drugs

Article Title: Marine Antimicrobial Peptide TP4 Exerts Anticancer Effects on Human Synovial Sarcoma Cells via Calcium Overload, Reactive Oxygen Species Production and Mitochondrial Hyperpolarization

doi: 10.3390/md19020093

Figure Lengend Snippet: TP4 induces mitochondrial hyperpolarization and mitochondrial ROS generation. SW982 ( A , B ) and AsKa-SS ( C , D ) cells were treated with TP4 (20 μg/mL) for 0, 15, 30, 60, 180 and 300 min. TMRE intensity was analyzed by flow cytometry. SW982 ( E , F ) and AsKa-SS ( G , H ) cells were treated with TP4 (20 μg/mL), as described in ( A – D ), followed by MitoSOX Red (5 μM) for an additional 15 min. MitoSOX Red fluorescence intensity was determined by flow cytometry. *: p < 0.05 (Compared to 0 min).

Article Snippet: The SW982 human synovial sarcoma cell line was purchased from ATCC (The Global Bioresource Center; Manassas, VA, USA).

Techniques: Flow Cytometry, Fluorescence

TP4 triggers calcium overload. SW982 ( A , B ) and AsKa-SS ( C , D ) cells were preloaded with Fluo-4 (5 μM) for 15 min, followed by TP4 treatment. After 0, 15, 30, 60, 180 or 300 min, Fluo-4 intensity was analyzed by flow cytometry. *: p < 0.05 (compared to 0 min). SW982 ( E , F ) and Aska-SS ( G ) cells were preincubated with BAPTA (10 μM) for 1 h, followed by TP4 (20 μg/mL) for 5 h. Then, cells were incubated with DCF-DA for 15 min. DCF-DA intensity was analyzed by flow cytometry. *: p < 0.05 (Vehicle vs. TP4; TP4 vs. TP4 + BAPTA). SW982 ( H ) and AsKa-SS ( I ) cells were preincubated with BAPTA (10 μM) for 1 h, followed by TP4 (20 μg/mL) for an additional 5 h. Cell viability was determined using the trypan exclusion assay. *: p < 0.05 (Vehicle vs. TP4; TP4 vs. TP4 + BAPTA). SW982 ( J ) and AsKa-SS ( K , L ) cells were incubated with TP4 (20 μg/mL) for 300 min. TMRE intensity was analyzed by flow cytometry. *: p < 0.05 (Vehicle vs. TP4; TP4 vs. TP4 + BAPTA).

Journal: Marine Drugs

Article Title: Marine Antimicrobial Peptide TP4 Exerts Anticancer Effects on Human Synovial Sarcoma Cells via Calcium Overload, Reactive Oxygen Species Production and Mitochondrial Hyperpolarization

doi: 10.3390/md19020093

Figure Lengend Snippet: TP4 triggers calcium overload. SW982 ( A , B ) and AsKa-SS ( C , D ) cells were preloaded with Fluo-4 (5 μM) for 15 min, followed by TP4 treatment. After 0, 15, 30, 60, 180 or 300 min, Fluo-4 intensity was analyzed by flow cytometry. *: p < 0.05 (compared to 0 min). SW982 ( E , F ) and Aska-SS ( G ) cells were preincubated with BAPTA (10 μM) for 1 h, followed by TP4 (20 μg/mL) for 5 h. Then, cells were incubated with DCF-DA for 15 min. DCF-DA intensity was analyzed by flow cytometry. *: p < 0.05 (Vehicle vs. TP4; TP4 vs. TP4 + BAPTA). SW982 ( H ) and AsKa-SS ( I ) cells were preincubated with BAPTA (10 μM) for 1 h, followed by TP4 (20 μg/mL) for an additional 5 h. Cell viability was determined using the trypan exclusion assay. *: p < 0.05 (Vehicle vs. TP4; TP4 vs. TP4 + BAPTA). SW982 ( J ) and AsKa-SS ( K , L ) cells were incubated with TP4 (20 μg/mL) for 300 min. TMRE intensity was analyzed by flow cytometry. *: p < 0.05 (Vehicle vs. TP4; TP4 vs. TP4 + BAPTA).

Article Snippet: The SW982 human synovial sarcoma cell line was purchased from ATCC (The Global Bioresource Center; Manassas, VA, USA).

Techniques: Flow Cytometry, Incubation, Exclusion Assay

Cytotoxicity of epinecidin-1 (epi-1) on human synovial sarcoma cells. SW982 cells were treated with indicated doses of epi-1 for 5 h. Cytotoxicity was analyzed by the trypan blue exclusion assay ( A ) and MTS/PMS assay ( B ). Cells were treated with epi-1 (6.125 μM) at different time points (0.5, 1, 3, 5 h). Cytotoxicity was analyzed by the trypan blue exclusion assay ( C ) and MTS/PMS assay ( D ). Cells were treated with epi-1 (6.125 μM) or scrambled epi-1 (scr-epi-1) (6.125 μM) for 5 h, and cytotoxicity was determined by the trypan blue exclusion assay ( E ) and MTS/PMS assay ( F ). * p < 0.05 was considered significant.

Journal: International Journal of Molecular Sciences

Article Title: Calcium-Dependent Calpain Activation-Mediated Mitochondrial Dysfunction and Oxidative Stress Are Required for Cytotoxicity of Epinecidin-1 in Human Synovial Sarcoma SW982 Cells

doi: 10.3390/ijms21062109

Figure Lengend Snippet: Cytotoxicity of epinecidin-1 (epi-1) on human synovial sarcoma cells. SW982 cells were treated with indicated doses of epi-1 for 5 h. Cytotoxicity was analyzed by the trypan blue exclusion assay ( A ) and MTS/PMS assay ( B ). Cells were treated with epi-1 (6.125 μM) at different time points (0.5, 1, 3, 5 h). Cytotoxicity was analyzed by the trypan blue exclusion assay ( C ) and MTS/PMS assay ( D ). Cells were treated with epi-1 (6.125 μM) or scrambled epi-1 (scr-epi-1) (6.125 μM) for 5 h, and cytotoxicity was determined by the trypan blue exclusion assay ( E ) and MTS/PMS assay ( F ). * p < 0.05 was considered significant.

Article Snippet: Human synovial sarcoma cell line SW982 was purchased from the Bioresource Collection and Research Center (Hsinchu, Taiwan).

Techniques: Trypan Blue Exclusion Assay